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Abstract 36 
Members of the ST127 uropathogenic E. coli (UPEC) clone have a high virulence 37 
potential based on gene carriage and they are highly virulent in insect infection 38 
models. However, strains of this lineage are reported in relatively low numbers in 39 
many studies. ST127 strains are also usually widely susceptible to antibiotics and, 40 
consequently, their true prevalence may be under-recognised, as they will be 41 
eradicated during empiric therapy. A genuine concern is the possibility that members 42 
of this highly virulent lineage will acquire resistance, leading to a more serious threat. 43 
The aim of this study was to design and validate a PCR assay specific to ST127. 44 
Genomic sequences obtained from various UPEC isolates from the leading clones 45 
were used in comparative genomics to allow identification of highly discriminative 46 
sequences specific to E. coli ST127. The fliC (flagellin) and a homologue of the 47 
upaG (Autotransporter adhesin) gene were identified as meeting our criteria and 48 
were used to develop a multiplex PCR assay. A total of 143 E. coli UPEC isolates 49 
representing 99 different MLST clones from three locations (North West and South 50 
West England and Riyadh, Saudi Arabia) were used to validate the PCR assay. The 51 
multiplex PCR readily identified all 29 E. coli ST127 isolates, but equally importantly, 52 
produced no false positives with representatives of any of the other 98 ST’s tested. 53 
We report the design and validation of a specific multiplex PCR for the rapid and 54 
reliable identification of ST127, which can be used for enhanced surveillance for this 55 
high-risk clone.   56 
 57 
Introduction  58 
Escherichia coli ST127 is a recently emerged clone (1) responsible for a significant 59 
proportion of extra-intestinal infections primarily of the urinary tract (1) but it has also 60 
been implicated in blood stream infections (BSI) (2, 3) and necrotizing enterocolitis in 61 
preterm infants (4). Members of the ST127 clone possess the common 62 
uropathogenic O6 serotype (5) and display an increased lethality in comparison to 63 
the more common UPEC ST lineages (ST73, ST131, ST95) with an in vivo model of 64 
infection (Galleria  mellonella) (6). Additionally, ST127 strains consistently exhibit 65 
higher scores in virulence factor PCR based assays compared to representatives of 66 
some of the more frequently encountered UPEC STs (1, 6-9). Members of the 67 
ST127 clone are often reported in relatively low, but significant proportions in 68 
prevalence studies (1, 10, 11). 69 
In general, ST127 isolates are fully susceptible to antibiotics commonly used for the 70 
empirical treatment of urinary tract infection (UTI) (7, 11, 12). They are, therefore, 71 
likely to be relatively under-represented in most published prevalence surveys, given 72 
that such studies are frequently based on UPEC isolates collected from clinical 73 
laboratories from individuals who have failed antimicrobial therapy; empirical therapy 74 
will usually result in elimination of ST127 isolates. Studies from Europe, Canada, 75 
Saudi Arabia and Japan (1, 3, 7, 10, 13) report ST127 at low, but often significant 76 
levels. A recent study by Yamanji and colleagues (14) focused on community 77 
acquired UTI (CA-UTI) within a Californian university community. This study found 78 
ST127 to be the second most prevalent strain increasing from 11% in 1999-2000 to 79 
16% in 2016-2017. In light of this recent evidence and reports of emerging 80 
resistance to antibiotics, including the cephalosporins, in ST127 isolates (8, 15, 16), 81 
members of this lineage are increasingly becoming a cause for clinical concern and 82 
give this strain the potential to emerge as a significant threat to human health. 83 
Ongoing surveillance of this high-risk clone is, therefore, important. 84 
Multi-locus Sequence Typing (MLST) has been extremely beneficial with the 85 
identification of common lineages associated with UTI and BSI. However, MLST is 86 
costly and time consuming, therefore, being impractical for the rapid identification of 87 
members of the ST127 clone. One solution to these problems is the development of 88 
ST specific PCR assays, as have been designed for other STs (17-19) and have 89 
been shown to be very useful in surveillance or in the examination of large culture 90 
collections. With the use of comparative genomics and clinical isolates, for the first 91 
time, we report the design and validation of a 3-gene multiplex PCR, incorporating 92 
an extraction/PCR control and two ST127 specific targets. The assay is 93 
unambiguous in its interpretation and highly specific to E. coli ST127. It is easy to 94 
perform and can be used in a clinical setting to quickly monitor the prevalence and 95 
dissemination of this recently emerged, highly virulent clone. 96 
 97 
Materials and Methods 98 
Strains 99 
A total of 10 ST127 and two ST73 isolates were obtained from the clinical 100 
laboratories at Derriford hospital (University Hospitals Plymouth, UK). Each isolate 101 
was recovered from non-duplicate patient urine samples that had been referred to 102 
the laboratory for standard microbiological examination for UTI. These ST73 and 103 
ST127 isolates were selected for genome sequence analysis from a wider collection 104 
of isolates collected between April 2015 and May 2015. The two ST73 isolates were 105 
included in the study as they were both isolated in the same urine specimen as one 106 
of the ST127 strains, originally identified as a recurrent monomicrobial UTI, but 107 
subsequently identified as three individual isolates with differing antimicrobial 108 
sensitivity patterns (data not shown). Isolates were identified as E. coli by 109 
biochemical and MALDI Biotyper analysis (Bruker Daltonics Inc.). MLST was 110 
performed on each of the 12 Derriford isolates using the Achtman scheme 111 
(http://mlst.warwick.ac.uk/mlst/dbs/Ecoli). In addition to the 12 isolates described 112 
above, a total of 131 previously typed UPEC isolates, representing 99 different STs, 113 
were obtained from earlier studies, 52 originating from Riyadh, Saudi Arabia (10), 78 114 
from North West England (including the ST131 reference strain EC958) (1, 20) and 115 
the reference ST127 strain 536 (21). 116 
A total of 29 ST127 isolates were used in the validation of our PCR screening assay. 117 
One of these was the well-documented 536 reference isolate and the remainder 118 
were clinical isolates from this and our previous studies. Fourteen isolates were 119 
confirmed as ST127 by whole genome sequencing and MLST loci Sanger 120 
sequencing, and the remaining 14 ST127 isolates identified using Sanger 121 
sequencing only. Routine cultures of all E. coli used in this study were grown 122 
aerobically at 37°C using Lysogeny Broth (LB) or LB agar.   123 
Genome sequencing, assembly and annotation of ST127 isolates 124 
Draft sequenced genomes were obtained for the 12 specimens isolated from 125 
Derriford hospital (10 ST127 and 2 ST73), 2 ST127 isolates from Saudi Arabia and 2 126 
from the North West of England. Sequencing of the E. coli isolates was performed on 127 
the Illumia platform by MicrobesNG (https://microbesng.uk/). The genomes were 128 
sequenced to a depth of between 48x and 94x coverage, raw sequence data 129 
assembled into contigs using SPAdes-3.9.0 (22) and the contigs ordered and aligned 130 
with reference to the UPEC ST127 536 genome (Accession ref |NC_008253 (23)) 131 
using Mauve 2.4.0 (Darling lab, University of Technology, Sydney). Sequences were 132 
concatenated using SeqHandler v0.5 (https://github.com/happykhan/seqhandler) and 133 
annotated using prokka 1.11 (24). Assembly quality was assessed using QUAST 4.0 134 
(25) and as an additional confirmation, genomes were uploaded to the Centre for 135 
Genomic Epidemiology MLST website (https://cge.cbs.dtu.dk/services/MLST) to 136 
corroborate the original MLST result. The predicted H antigen serotype of all 137 
sequenced ST127 isolates was determined using SerotypeFinder 1.1 138 
(26)(https://cge.cbs.dtu.dk/services/SerotypeFinder). The complete annotated 139 
chromosomes of the sequenced ST127 and ST73 isolates are available at the 140 
European Nucleotide Archive (ENA; http://www.ebi.ac.uk/ena) (Accession Number 141 
Pending). 142 
Comparative Genomics  143 
In addition to the UPEC sequence data obtained from the draft genomes listed 144 
above, a selection of publicly available genomes were downloaded from the NCBI 145 
(National Library of Medicine, Bethesda, Maryland, USA) database, including those 146 
for nine reference UPEC isolates and one asymptomatic bacteriuria strain (Table 1). 147 
Blast Ring Image Generator (BRIG 0.95-dev.0004) (27) 148 
(http://sourceforge.net/projects/brig) was used initially to compare all sequenced 149 
genomes to reveal regions in the ST127 genome that appeared to be absent in the 150 
genomes of UPEC form other STs. Regions of variability were examined further 151 
using the Artemis Comparison Tool 152 
(28)(http://www.sanger.ac.uk/science/tools/artemis-comparison-tool-act). Nucleotide 153 
and protein Blast searches (https://blast.ncbi.nlm.nih.gov, 154 
https://www.uniprot.org/blast/) were used to confirm  the putative ST127 specific 155 
genomic regions that were then targeted with PCR.  156 
Primer design and PCR protocol 157 
The PCR primer pairs were designed using CLC Genomics Work bench 7.5.1 158 
(https://www.qiagenbioinformatics.com). Primer targets were based on the upaG 159 
autotransporter and fliC flagellin gene regions that showed little or no homology in 160 
non-ST127 genomes using the NCBI BLAST and UniProt databases. The well-161 
established MLST locus gyrB (DNA gyrase subunit B) primers (29) were 162 
incorporated into the multiplex PCR to act as an extraction/PCR control. Primer 163 
sequences, concentrations and amplicon size are listed in Table 2. DNA template for 164 
the PCR reaction was obtained via colony PCR. Briefly, a suspension of each isolate 165 
was made using material from overnight plate cultures in nuclease free water 166 
(NORMAPUR®, BDH Chemicals, VWR) to a turbidity equivalent to a 0.5 McFarland 167 
standard. This suspension was diluted 1:50 and 1.6µl used in the final PCR reaction.  168 
Each multiplex PCR reaction was performed using 10µl of 2X Biomix™ Red reaction 169 
mix (Bioline, London, UK) in a final PCR volume of 20 µl. A primer concentration of 170 
1pmol/µl, 1.3pmol/µl and 0.85pmol/µl was found to be most applicable for each of 171 
the upaG, fliC and gyrB primers, respectively, and 0.8µl of each primer was added to 172 
the PCR reaction. PCR was performed on a T100 Thermal cycler (BIO-RAD, 173 
Hertfordshire, UK) as follows: An initial denaturation at 98°C for 8 minutes followed 174 
by 36 cycles of 95°C for 30 seconds, 58°C for 1 minute and 72°C for 40 seconds, 175 
with a final extension of 72°C for 5 minutes. PCR amplification was visualised by 176 
running 5µl of the PCR product on a 1% agarose gel. Gel images were visualised 177 
under UV transillumination and the number and size of amplicon products 178 
determined. A positive ST127 isolate was identified by the presence of 3 distinct 179 
DNA bands (Fig. 2) each of the expected amplicon sizes (Table 2) and a negative 180 
reaction by the presence of the gyrB band alone or with just one of the 2 specific 181 
targets amplified. Amplification of the gyrB gene was necessary to determine a true 182 
negative result. 183 
Validation, sensitivity and specificity of ST127 specific PCR 184 
To determine the sensitivity and specificity of the assay, a total of 143 strains of E. 185 
coli (see strains section) were used to validate the multiplex PCR. The collection 186 
consisted of 29 ST127 strains and 114 UPEC isolates representing 98 different STs 187 
(Table 3).  188 
 189 
Results and Discussion 190 
Identification of gene regions specific to ST127 191 
Several regions on the ST127 genome were identified as having low homology to 192 
genomes of other UPEC STs, using BRIG comparisons (Fig. 1). Each locus that was 193 
identified with ≤70% homology underwent further investigation using blastn and 194 
blastp database comparisons, culminating with the identification of two gene variants 195 
highly specific to ST127, namely the fliC gene and a putative upaG gene.  196 
The fliC gene codes for the subunit protein flagellin, the major constituent of the 197 
flagellar filament. The polymorphic and antigenic properties of flagellin have been 198 
well studied since the 1930’s and form an integral part of the serological 199 
classification scheme. The flagellin proteins are conserved at terminal regions while 200 
the central region is variable and often carries an H-serotype specific epitope (30). 201 
The protein is also implicated in pathogen-associated interactions, stimulating the 202 
Toll-like 5 receptor (31) which, in turn, has given rise to the prospect of the more 203 
conserved regions of the flagellin protein becoming a potent adjuvant in the design of 204 
new vaccines for UTI (32, 33). Each of the sequenced ST127 genomes carried an 205 
identical 1668bp fliC gene, with the single exception in isolate SA189 (from Saudi 206 
Arabia), which exhibited a C to A substitution at position 699, producing only a 207 
synonymous mutation in a valine codon. Using SerotypeFinder 1.1 the ST127 fliC 208 
gene was seen to have 100% identity to the predicted serotype H31 variant, in 209 
agreement with previous reports for carriage of this serotype in ST127 strains (34). 210 
The conservation within UPEC ST127 isolates, coupled with the reported variability 211 
within the E. coli species and previously published studies employing fliC as a 212 
discriminatory marker with enteropathogenic E. coli (35), justified selection of fliC as 213 
a worthy candidate for ST127 specific PCR.  214 
The second locus identified as a putative ST127 marker, was a large 4875bp gene 215 
sequence that shared 73% identity with the upaG trimeric autotransporter (AT) 216 
protein found in E. coli CFT073 (36). The presumptive UpaG protein sequence in 217 
ST127 was found to share many structural features with E. coli CFT073 UpaG, the 218 
Yersinia yadA and Haemophilus influenza Hia AT genes, including specific 219 
homologies with the Hia and YadA proteins at the C-terminal region and the Left-220 
handed Beta-roll of YadA at the hydrophobic N-terminal region (37, 38). The 73% 221 
identity with the CFT073 UpaG is not surprising as variability within genera and 222 
species for the AT family of adhesins is particularly high. The membrane anchor is 223 
the only domain that remains homologous throughout the AT and, as such, defines 224 
the family (39). The yadA gene was identified in Yersinia species and originally 225 
named P1 (40) or autoagglutination protein (41) and to date remains the best 226 
characterised AT family of adhesins (42, 43). The AT adhesins are important 227 
virulence factors for many Gram-negative pathogens and, although they are 228 
universally associated with adherence to epithelial cells and extracellular matrix 229 
(ECM) proteins (36), their functions appear extensive with reported roles in biofilm 230 
formation (44), invasion into host cells (45) and serum resistance (46).  231 
Specificity and sensitivity of ST127 specific PCR 232 
Ideally, one PCR target would be used to identify this particular ST, but with the size 233 
and variability within the E. coli pan genome, it was believed that such a precise 234 
single PCR target may be over optimistic. However, the FliC flagellin PCR primers 235 
proved to be highly sensitive and specific for the UPEC isolates producing only three 236 
false positive results (ST372, ST420 and ST1529) and a sensitivity and specificity 237 
result of 100% and 97.3%, respectively. This suggests that the H31 serotype is less 238 
common amongst other UPEC strains and, although not exclusive to ST127, 239 
remains relatively specific. The upaG primers alone were less specific (92.1%) with 9 240 
non-ST127 isolates (ST14, ST80, ST141, ST537, ST540, ST550, ST785, ST807 and 241 
ST998) producing an amplicon from the upaG primers. However, three of these false 242 
positive results (ST14, ST550 and ST807) were easily distinguishable as negative as 243 
they produced a shortened amplicon in the range of 1000-1100bp (Fig. 3). 244 
The two primers used in combination gave 100% sensitivity and specificity when 245 
tested against the 143 isolates, representing strains from 99 diverse UPEC 246 
associated STs. The assay was optimised with and without the inclusion of the gyrB 247 
extraction/PCR control and using both purified DNA (data not shown) and colony 248 
PCR. On the rare occasion a weak upaG and/or fliC amplicon was observed during 249 
the validation, the PCR was retested with both the 3 locus multiplex PCR and with 250 
the gyrB primers removed from the reaction. The removal of the competing gyrB 251 
primers from the multiplex PCR can increase the concentration of ST127 specific 252 
target amplicons, thus enhancing visualisation of the ST127 specific bands. 253 
Although a PCR assay targeting a hypothetical protein for the detection of ST127 254 
has recently been published by Ciesielczuk et al (2), their study did not provide any 255 
assay conditions or clinical validation. Their PCR used a single locus to identify 256 
ST127 and, while our own in silico analysis predicts that their primers should have 257 
high specificity, with no laboratory validation of performance, the utility of this assay 258 
has not been confirmed. The three false positive results we found with our primers 259 
for fliC indicate that even primers which appear highly specific in silico may perform 260 
less well when used in practice. A significant finding of our study was that no single 261 
primer pair was able to reliably identify ST127 and to achieve this, a combination of 262 
PCR targets was required. Additionally, any specific PCR assay without the 263 
presence of an extraction/PCR control will always introduce an element of doubt 264 
upon obtaining a negative result. This will reduce the practicality for use in a 265 
diagnostic setting. Although our multiplex PCR approach successfully identified all 266 
ST127s from a large collection of UPEC STs and from the very different locations in 267 
the UK and Saudi Arabia, further confirmation of performance using isolates from 268 
other geographical locations would be of value. 269 
Concluding remarks 270 
The vast majority of uncomplicated CA-UTI are treated empirically leading to 271 
significant over-prescription and biasing the collections of isolates investigated in 272 
many studies, which include only isolates from clinical microbiology laboratories, i.e. 273 
isolates from cases where empirical therapy may have failed. Historically, members 274 
of the ST127 clone have been widely susceptible to first line empiric antibiotics, so 275 
will not feature in such culture collections. To greater understand the true genetic 276 
background of aetiological agents of UTI, it will be paramount that future CA-UTI 277 
studies focus on specimens collected from all patients at the point of care prior to 278 
empiric treatment. The investigations performed by Yamaji and colleagues (14) go 279 
some way to emphasise the importance of such studies. In their work, ST127 was 280 
found to be the second most common lineage in a presumably young and healthy 281 
Californian student cohort, in contrast to reports of low prevalence from other studies 282 
involving some selection bias (1, 3, 7, 10). It is understood that the presence of 283 
antimicrobial resistance in a pathogen is a prerequisite for increased prevalence, 284 
however, in the case of Extra-intestinal Pathogenic E. coli (ExPEC), resistance may 285 
not be the dominant driver towards increased prevalence. Recent studies show that 286 
drug resistant and drug susceptible strains have both remained equally prevalent in 287 
UTI and BSI over the last 17 and 11 years, respectively (14, 47). Furthermore, in the 288 
case of the globally disseminated ST131 clone, acquisition of specific virulence 289 
determinants predates the mutations in the gyrA and parC genes that led to the 290 
development of fluoroquinolone resistance in Clade C2 strains carrying the CTX-M-291 
15 ESBL gene (48). This suggests that the presence or acquisition of virulence 292 
genes in ExPEC may be the necessary precursor towards the future success of a 293 
pathogen. The high virulence potential of ST127 is of clinical concern and evidence 294 
for the increase in CA-UTI warrants increased surveillance for members of this ST.      295 
Here, we report the first validated multiplex PCR for detection of E. coli multi-locus 296 
Sequence Type 127. The assay is simple, yet highly discriminatory, rapid, robust, 297 
reliable and inexpensive. The multiplex PCR can also be performed directly from 298 
individual colonies removing the need for any extraction or DNA purification 299 
protocols. We suggest that such assays have an central place in surveillance for 300 
important UPEC clones. We urge laboratories to increase surveillance for ST127 301 
isolates, on a prospective basis, to reduce the potential impact of isolates from this 302 
virulent clone that are increasingly being shown to acquire resistance. 303 
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 465 
Table headings and figure legends 466 
Table 1. List of E. coli strains and their designated sequence types recovered from 467 
the NCBI database and used for comparative genomics. 468 
Table 2. Details of primers used in multiplex PCR to detect members of the ST127 469 
clone 470 
Table 3. List of all UPEC isolates and their designated sequence types that were 471 
used for validation of the ST127 specific PCR assay 472 
Figure 1. Comparison of the genomes of 25 UPEC and one asymptomatic 473 
bacteriuria E. coli isolate. The inner circle represents the reference sequence EC536 474 
with the inner red rings representing genomes of ST127, 10 originating from 475 
Derriford hospital, 2 from Saudi Arabia and 2 from North West England. The green 476 
circles represent non-ST127 isolates, 2 ST73 isolates from Derriford hospital and 9 477 
genomes download from the NCBI database. Blank gaps in the rings represent ≤70% 478 
homology and shaded areas represent ≤90% homology. The red arrows indicate the 479 
position of fliC and upaG genes. The image was prepared using Blast Ring Image 480 
Generator.     481 
Figure 2. PCR detection for members of the ST127 clone. The gyrB band (911bp) 482 
corresponds to the Extraction/PCR control amplified in all isolates. The upaG and 483 
fliC bands both amplified in the same reaction correspond only to isolates from the 484 
ST127 clone strains. Lanes 1-6 consisted of ST127 isolates, lanes 7-9 non-ST127 485 
isolates. Lane 1, NW41; lane 2, D3; lane 3, D4; lane 4, NW72; lane 5, NW112; lane 486 
6, NW154; lane 7, NW153 (ST1529 fliC+), lane 8, SA027 (ST537 upaG+); Lane 9, 487 
EC958 (ST131) and M, 1kb molecular weight marker (Bioline, London, UK).   488 
Figure 3. Routine testing of upaG-gyrB-fliC ST127 specific PCR. Lanes 3, 9, 10, 13-489 
16 and 19 were ST127 isolates, positive for 3 gene loci. Lanes 1-2, 4-8, 11-12, 17-18 490 
and 20-24 were non-ST127 isolates. Lanes 20 and 23 (ST80 and ST550, 491 
respectively) are examples of a weak upaG positive (lane 20) and a upaG positive 492 
(lane 23) of reduced amplicon length causing the upaG amplicon to merge with the 493 
gyrB amplicon. M, 1kb molecular weight marker.      494 
 495 
496 
Table 1.  497 
UPEC 
Isolate 
Sequence 
Type 
NCBI Bioproject Accession No. 
/ Reference sequence 
ABU 83972  ST73 PRJNA38725 
CFT073  ST73 PRJNA313 
NA114  ST131 PRJNA66975 
EC958 ST131 NZ_HG941718.1 
UMN026  ST597 PRJNA33415 
IAI39  ST62 PRJNA33411 
EC536 ST127 NC_008253 
UTI89 ST95 PRJNA16259 
VR50 ST10 PRJEA61445 
clone D i2 ST73 PRJNA52021 
 498 
 499 
Table 2.  500 
Gene Primer 
direction 
Primer Sequence (5’-3’) Final primer 
concentration 
(µM) 
Product  
Length 
(bp) 
Reference 
upaG Forward GATAGGCAAGGACGCAAGA 0.04 1218 This study 
 Reverse GGTCGCAATATCCGTAGT 0.04 This study 
fliC Forward CATTAATACCAACAGCCTC 0.052 538 This study 
 Reverse TATTAGCCACAGCCCCTT 0.052 This study 
gyrB Forward TCGGCGACACGGATGACGGC 0.034 911 (29) 
 Reverse ATCAGGCCTTCACGCGCATC 0.034 (29) 
 501 
502 
Table 3.  503 
E. coli 
Isolate* 
MLST E. coli 
Isolate 
MLST E. coli 
Isolate 
MLST E. coli 
Isolate 
MLST E. coli 
Isolate 
MLST 
SA014 10 NW45 104 NW224 127 SA067 624 SA060 1380 
SA036 10 NW155 117 EC958 131 SA119 662 SA061 1431 
SA097 10 D9 127 NW002 131 NW178 681 NW153 1529 
SA098 10 D39 127 NW014 131 NW130 779 NW169 1532 
SA135 10 D124A 127 NW59 136 NW140 780 NW174 1533 
SA140 10 D124B 127 NW82 141 NW141 781 NW192 1534 
NW006 10 D263A 127 SA053 153 NW57 782 NW193 1535 
NW212 14 D264 127 SA005 155 NW016 783 NW203 1536 
SA004 23 D298 127 SA013 162 NW007 784 NW220 1537 
SA023 38 D316 127 NW39 224 NW63 785 NW221 1538 
SA034 38 D354 127 SA082 315 NW74 786 NW225 1540 
NW65 48 D468 127 SA035 347 NW34 787 NW226 1541 
SA072 52 EC536 127 SA012 367 NW36 804 NW235 1542 
SA217 57 NW18 127 SA010 371 NW40 805 NW236 1543 
NW38 58 NW41 127 NW27 372 NW41 806 NW237 1544 
NW79 59 SA009 127 NW80 393 NW42 807 NW244 1545 
NW56 62 SA028 127 NW175 399 NW43 808 NW245 1546 
NW019 69 SA033 127 NW53 405 NW47 809 NW245 1547 
D263B 73 SA039 127 NW98 410 SA042 998 SA062 1611 
D263C 73 SA126 127 NW165 420 NW011 999 SA137 2020 
NW009 73 SA151 127 NW87 448 NW49 1000 SA109 2659 
NW012 73 SA153 127 SA161 449 NW61 1001 SA198 3076 
NW013 73 SA168 127 SA026 450 NW71 1002 SA030 3556 
NW015 73 SA174 127 NW179 493 NW78 1003   
NW001 80 SA189 127 SA132 501 NW86 1004   
NW017 88 SA191 127 SA027 537 NW88 1005   
NW003 95 SA218 127 SA063 540 SA167 1196   
NW33 95 NW72 127 SA099 543 SA123 1266   
SA056 101 NW112 127 NW004 550 NW171 1303   
SA081 101 NW154 127 SA116 617 SA142 1312   
*The prefix determines the location where the isolate originated from, D; Derriford 504 
hospital, SA; Saudi Arabia and NW; North West England, EC; reference strains. 505 
506 
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